Continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groups

Continuous glucose monitoring (CGM) systems are an emerging technology that allows frequent glucose measurements to monitor glucose trends in real time. Their use as a diagnostic tool is still developing and appears to be promising. Combining intermittent glucose self-monitoring (SGM) and CGM combin...

Full description

Bibliographic Details
Main Authors: Ashraf Soliman, Vincenzo DeSanctis, Mohamed Yassin, Rania Elalaily, Nagwa E Eldarsy
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2014;volume=18;issue=3;spage=274;epage=282;aulast=Soliman
id doaj-35ed1ddb344042babf6f7b98c8c5038a
record_format Article
spelling doaj-35ed1ddb344042babf6f7b98c8c5038a2020-11-24T22:33:41ZengWolters Kluwer Medknow PublicationsIndian Journal of Endocrinology and Metabolism2230-82102230-95002014-01-0118327428210.4103/2230-8210.131130Continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groupsAshraf SolimanVincenzo DeSanctisMohamed YassinRania ElalailyNagwa E EldarsyContinuous glucose monitoring (CGM) systems are an emerging technology that allows frequent glucose measurements to monitor glucose trends in real time. Their use as a diagnostic tool is still developing and appears to be promising. Combining intermittent glucose self-monitoring (SGM) and CGM combines the benefits of both. Significant improvement in the treatment modalities that may prevent the progress of prediabetes to diabetes have been achieved recently and dictates screening of high risk patients for early diagnosis and management of glycemic abnormalities. The use of CGMS in the diagnosis of early dysglycemia (prediabetes) especially in high risk patients appears to be an attractive approach. In this review we searched the literature to investigate the value of using CGMS as a diagnostic tool compared to other known tools, namely oral glucose tolerance test (OGTT) and measurement of glycated hemoglobin (HbA1C) in high risk groups. Those categories of patients include adolescents and adults with obesity especially those with family history of type 2 diabetes mellitus, polycystic ovary syndrome (PCO), gestational diabetes, cystic fibrosis, thalassemia major, acute coronary syndrome (ACS), and after renal transplantation. It appears that the ability of the CGMS for frequently monitoring (every 5 min) glucose changes during real-life settings for 3 to 5 days stretches the chance to detect more glycemic abnormalities during basal and postprandial conditions compared to other short-timed methods.http://www.ijem.in/article.asp?issn=2230-8210;year=2014;volume=18;issue=3;spage=274;epage=282;aulast=SolimanContinuous glucose monitoring systemGlycated hemoglobin (HbA1C)obesityoral glucose tolerance testthalassemia
collection DOAJ
language English
format Article
sources DOAJ
author Ashraf Soliman
Vincenzo DeSanctis
Mohamed Yassin
Rania Elalaily
Nagwa E Eldarsy
spellingShingle Ashraf Soliman
Vincenzo DeSanctis
Mohamed Yassin
Rania Elalaily
Nagwa E Eldarsy
Continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groups
Indian Journal of Endocrinology and Metabolism
Continuous glucose monitoring system
Glycated hemoglobin (HbA1C)
obesity
oral glucose tolerance test
thalassemia
author_facet Ashraf Soliman
Vincenzo DeSanctis
Mohamed Yassin
Rania Elalaily
Nagwa E Eldarsy
author_sort Ashraf Soliman
title Continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groups
title_short Continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groups
title_full Continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groups
title_fullStr Continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groups
title_full_unstemmed Continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groups
title_sort continuous glucose monitoring system and new era of early diagnosis of diabetes in high risk groups
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Endocrinology and Metabolism
issn 2230-8210
2230-9500
publishDate 2014-01-01
description Continuous glucose monitoring (CGM) systems are an emerging technology that allows frequent glucose measurements to monitor glucose trends in real time. Their use as a diagnostic tool is still developing and appears to be promising. Combining intermittent glucose self-monitoring (SGM) and CGM combines the benefits of both. Significant improvement in the treatment modalities that may prevent the progress of prediabetes to diabetes have been achieved recently and dictates screening of high risk patients for early diagnosis and management of glycemic abnormalities. The use of CGMS in the diagnosis of early dysglycemia (prediabetes) especially in high risk patients appears to be an attractive approach. In this review we searched the literature to investigate the value of using CGMS as a diagnostic tool compared to other known tools, namely oral glucose tolerance test (OGTT) and measurement of glycated hemoglobin (HbA1C) in high risk groups. Those categories of patients include adolescents and adults with obesity especially those with family history of type 2 diabetes mellitus, polycystic ovary syndrome (PCO), gestational diabetes, cystic fibrosis, thalassemia major, acute coronary syndrome (ACS), and after renal transplantation. It appears that the ability of the CGMS for frequently monitoring (every 5 min) glucose changes during real-life settings for 3 to 5 days stretches the chance to detect more glycemic abnormalities during basal and postprandial conditions compared to other short-timed methods.
topic Continuous glucose monitoring system
Glycated hemoglobin (HbA1C)
obesity
oral glucose tolerance test
thalassemia
url http://www.ijem.in/article.asp?issn=2230-8210;year=2014;volume=18;issue=3;spage=274;epage=282;aulast=Soliman
work_keys_str_mv AT ashrafsoliman continuousglucosemonitoringsystemandneweraofearlydiagnosisofdiabetesinhighriskgroups
AT vincenzodesanctis continuousglucosemonitoringsystemandneweraofearlydiagnosisofdiabetesinhighriskgroups
AT mohamedyassin continuousglucosemonitoringsystemandneweraofearlydiagnosisofdiabetesinhighriskgroups
AT raniaelalaily continuousglucosemonitoringsystemandneweraofearlydiagnosisofdiabetesinhighriskgroups
AT nagwaeeldarsy continuousglucosemonitoringsystemandneweraofearlydiagnosisofdiabetesinhighriskgroups
_version_ 1725729834899865600